In conclusion, it is feasible that NF-κB can affect NAFLD and its related complications by regulating IL-6 to regulate inflammation, lipid metabolism, fatty acid oxidation, and insulin sensitivity. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.